Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-108287
Filing Date
2026-03-16
Accepted
2026-03-16 16:00:21
Documents
90
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cue-20251231.htm   iXBRL 10-K 3296618
2 DESC OF COMMON STOCK cue-ex4_2.htm EX-4.2 33686
3 STOCK OPTION GRANT ISO cue-ex10_14.htm EX-10.14 40033
4 STOCK OPTION GRANT ISO cue-ex10_15.htm EX-10.15 38073
5 DIRECTOR COMP POLICY cue-ex10_20.htm EX-10.20 23649
6 LUCINDA WARREN EMPLOYMENT AGREEMENTS cue-ex10_27.htm EX-10.27 207174
7 MATTEO SEPARATION cue-ex10_28.htm EX-10.28 74045
8 IMSCP AGREEMENT cue-ex10_49.htm EX-10.49 594996
9 LIST OF SUBS cue-ex21_1.htm EX-21.1 10034
10 CONSENT RSM cue-ex23_1.htm EX-23.1 5721
11 CERTIFICATION USMAN AZAM cue-ex31_1.htm EX-31.1 15839
12 CERTIFICATION LUCINDA WARREN cue-ex31_2.htm EX-31.2 16123
13 OZ AND CINDY CERT SOX 909 cue-ex32_1.htm EX-32.1 12800
14 GRAPHIC img187777037_0.jpg GRAPHIC 499951
15 GRAPHIC img187777037_1.jpg GRAPHIC 499951
  Complete submission text file 0001193125-26-108287.txt   15815970

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20251231.xsd EX-101.SCH 1919682
94 EXTRACTED XBRL INSTANCE DOCUMENT cue-20251231_htm.xml XML 1776621
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38327 | Film No.: 26756468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)